Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines

Experimental Dermatology
Naoko SumitaChikako Nishigori

Abstract

Signal transducer and activator of transcription 3 (Stat3), a cytoplasmic transcription factor, is constitutively activated in various types of cancer. Previous investigations have demonstrated that Stat3 plays important roles in cell growth, survival, differentiation, and transformation. The constitutive activation of Stat3 in human malignancies is an important key to maintain the characteristics of a malignant tumor, such as the rate of proliferation and/or immortalization, and inhibition of Stat3 function could be a potent therapeutic approach. In order to elucidate the role of Stat3 in tumors, cutaneous squamous cell carcinoma (SCC) cells, which have constitutive activation of Stat3 in vivo and in vitro, were used for this study. To investigate the effect of specific inhibition of Stat3 in SCC cells, we developed small interfering RNAs (siRNAs) that target Stat3, and which effectively prevent its expression in vitro. Introduction of Stat3 siRNA into SCC cells led to inhibition of growth and changes in morphology but did not induce apoptosis. Stat3 siRNA-transfected SCC cells had impaired tumor growth in nude mice. These findings demonstrate that Stat3 plays a critical role in the tumorigenesis, but not in the cell survival,...Continue Reading

References

Aug 24, 1999·Cell·J F BrombergJ E Darnell
Sep 24, 1999·Developmental Biology·J U LohmannT C Bosch
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y ShenJ F Bromberg
Feb 23, 2002·The Journal of Biological Chemistry·Li Li, Peter E Shaw
Sep 19, 2003·BMC Cancer·Liza KonnikovaBrent H Cochran
May 29, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kate SumpterJo Congleton
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tobias N DechowJacqueline F Bromberg
Sep 21, 2004·Oncogene·Hui SongJiayuh Lin
Nov 19, 2004·International Journal of Clinical Oncology·Fumiyoshi OhyanagiYasutsuna Sasaki
Apr 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sangkil NamRichard Jove

❮ Previous
Next ❯

Citations

Jul 20, 2011·ACS Chemical Biology·Yuelong MaAndrew M Scott
Dec 25, 2007·International Immunology·Magdalena HuberMichael Lohoff
Jan 1, 2009·Journal of Oncology·Jennifer FreytagPaul J Higgins
Jan 16, 2014·Journal of Experimental & Clinical Cancer Research : CR·Kazuhiro YamamotoMidori Hirai
Jul 16, 2008·Seminars in Cell & Developmental Biology·Bernd GronerCorina Borghouts
Jan 8, 2017·Photochemistry and Photobiology·Mary K Montes de OcaFarrukh Afaq
Nov 18, 2006·The Kaohsiung Journal of Medical Sciences·Sheau-Fang YangChee-Yin Chai
Nov 6, 2014·Experimental and Therapeutic Medicine·Aihong MengYuna Shi
Jul 28, 2016·Molecular Cancer·Agustí TollInmaculada Hernández-Muñoz
Feb 27, 2021·Cancer Treatment and Research Communications·Neftali VazquezMegan Keniry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.